Litcius/Paper detail

Safety, immunogenicity, and efficacy of NDV-3A against Staphylococcus aureus colonization: A phase 2 vaccine trial among US Army Infantry trainees

Eugene V. Millar, Jason W. Bennett, Burc Barin, Patrick Carey, Natasha N. Law, Caroline E. English, Michael M. Schwartz, Terrence Cochrane, Michael W. Ellis, David R. Tribble, M. Timothy Cooke, John P. Hennessey

2021Vaccine19 citationsDOIOpen Access PDF

Topics & Concepts

MedicineReactogenicityStaphylococcus aureusVaccinationPopulationImmunogenicityImmunologyInternal medicineAntigenBiologyBacteriaGeneticsEnvironmental healthAntimicrobial Resistance in StaphylococcusAntifungal resistance and susceptibilityReproductive tract infections research
Safety, immunogenicity, and efficacy of NDV-3A against Staphylococcus aureus colonization: A phase 2 vaccine trial among US Army Infantry trainees | Litcius